Intellectual Property

TearSolutions, Inc - Natural Therapy for dry eye

Growing Worldwide Patent Portfolio

  • 2008: ‘Ocular Tear Growth Factor-Like Protein’ – Laurie, G.W., et al., U.S. Patents 7,320,870.  Method of use.
  • 2008: ‘Ocular Tear Growth Factor-Like Protein’ – Laurie, G.W., et al., U.S. Patents 7,459,440.  Method of use.
  • 2009: ‘Ocular Tear Growth Factor-Like Protein’ – Laurie, G.W., et al., Japan Patent 4288070.  Composition of matter and method of use.
  • 2010: ‘Use of Lacritin in Promoting Ocular Cell Survival’ – Laurie, G.W., and Wang, J. US  Patent 7,648,964 B2.   Method of use.
  • 2011: ‘Lacritin-Syndecan Fusion Proteins’ – Laurie, G.W., and Ma, P., U.S. Patent 7,932,227 B1.   Composition of matter and method of use.
  • 2012: ‘Use of Lacritin in Promoting Ocular Cell Survival’ – Laurie, G.W., and Wang, J. European Patent 1766768.   Composition of matter and method of use.
  • 2012: ‘Ocular Tear Growth Factor-Like Protein’ – Laurie, G.W., et al., Canada Patent 2,438,334.  Composition of matter and method of use.
  • 2013: ‘Use of Lacritin in Promoting Ocular Cell Survival’ – Laurie, G.W., et al., Japan Patent 5122278.

Pending:

  • 2014: ‘Compositions and Methods for the Delivery of Drugs to the Ocular Surface by Contact Lenses’ – Mackay JA, Wang W, Laurie GW.  PCT/US2014/32412 [option]
  • 2015: ‘Compositions and Methods for Treating Eye Infections and Disease’ – Laurie GW.  PCT/US2015/19964
  • 2016: ‘Tear Film Lipid Stabilizer for Dry Eye’ – Laurie GW, Georgi Georgiev.  PCT/62/383/858
  • 2017: ‘Stable Peptide Compositions’ – Laurie GW, Laskar P.  PCT/62/461/467
  • 2017: ‘Stable Peptide Compositions’ – Laurie GW, Laskar P, Gadek T.  PCT/62/504/854
  • 2017: ‘Stable Peptide Compositions’ – Carpenter M, Odrich M, Laurie GW, Laskar P, Gadek T. PCT/62/530,565